Regeneron Pharma (REGN) PT Lowered to $720 at Jefferies

November 6, 2020 8:29 AM

Jefferies analyst Biren Amin lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $720.00 (from $730.00) while maintaining a Buy rating.

No results found